{"id":298515,"date":"2026-10-09T13:07:53","date_gmt":"2026-10-09T07:37:53","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=298515"},"modified":"2026-10-09T13:07:53","modified_gmt":"2026-10-09T07:37:53","slug":"marksans-pharma-share-price-prediction-2027","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/marksans-pharma-share-price-prediction-2027\/","title":{"rendered":"Marksans Pharma Share Price Prediction 2027: Scenario Targets, Valuation and Technical Outlook"},"content":{"rendered":"

CMP Rs 309.00 (9 Oct 2026). 52W range Rs 155.00 to Rs 350.95. PE 26.77. 2027 base Rs 354, bull Rs 425.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

The Marksans Pharma share price forecast for 2027 centres on a conservative case of Rs 339, a base case of Rs 354 and a bull case of Rs 425, against a current price of Rs 309.00. These targets scale today’s price by reported EPS growth at a constant PE multiple, so they rest on earnings the company has already delivered, not on broker forecasts. The base case implies 14.6% upside from today’s price. The daily technical setup reads neutral.<\/p>\n<\/p><\/div>\n

Marksans Pharma share price prediction 2027 comes down to earnings growth and the multiple investors pay for it, and the reported numbers give a measured answer. The stock trades at Rs 309.00 on NSE as of 9 October 2026, 12.0% below its 52-week high of Rs 350.95, after the company reported net profit of Rs 420.06 crore for FY26.<\/p>\n

This Marksans Pharma stock forecast 2027 builds conservative, base and bull scenarios from exchange-reported financials, shareholding data and daily price indicators, with every assumption shown.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n